Does greater adiposity increase blood pressure and hypertension risk?: Mendelian randomization using the FTO/MC4R

Nicholas J Timpson1, Roger Harbord, George Davey Smith

  • 1Medical Research Council Centre for Causal Analysis in Translational Epidemiology, Bristol University, United Kingdom.

Insights

Elevated body mass index (BMI) significantly increases blood pressure, raising cardiovascular event risk. Reducing BMI offers substantial benefits for lowering hypertension and related morbidity.

Area of Science:

  • Cardiovascular Epidemiology
  • Human Genetics
  • Metabolic Disorders

Background:

  • Elevated blood pressure is a major risk factor for cardiovascular events such as myocardial infarction and stroke.
  • Observational studies suggest a causal link between body mass index (BMI) and hypertension, but are susceptible to confounding and reverse causation.
  • Unbiased estimation of the association between adiposity and blood pressure is crucial for public health interventions.

Purpose of the Study:

  • To estimate the unconfounded and unbiased association between body mass index (BMI) and blood pressure using instrumental variable methods.
  • To confirm observational findings regarding the relationship between BMI and hypertension, mitigating potential biases.

Main Methods:

  • Utilized instrumental variable analysis within the Copenhagen General Population Study.
  • Employed specific genetic variants, rs9939609 (FTO) and rs17782313 (MC4R), as instrumental variables for BMI.
  • Accounted for participants receiving antihypertensive medication through appropriate adjustments.

Main Results:

  • Confirmed a positive association between BMI and blood pressure, free from confounding and reverse causation.
  • A 10% increase in BMI was associated with a 3.85 mm Hg rise in systolic blood pressure (P=0.0002).
  • A 10% increase in BMI was associated with a 1.79 mm Hg rise in diastolic blood pressure (P=0.002).

Conclusions:

  • Body mass index has a significant causal impact on blood pressure.
  • The observed associations are substantial, highlighting the potential for considerable reductions in cardiovascular morbidity.
  • Reducing body mass index presents a key strategy for mitigating hypertension and its associated health risks.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors: